151 related articles for article (PubMed ID: 11221916)
1. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, decrease agonist-induced contractions of the pig isolated ureter.
Mastrangelo D; Wisard M; Rohner S; Leisinger H; Iselin CE
Urol Res; 2000 Dec; 28(6):376-82. PubMed ID: 11221916
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective inhibitors of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2) on the spontaneous myogenic contractions in the upper urinary tract of the guinea-pig and rat.
Davidson ME; Lang RJ
Br J Pharmacol; 2000 Feb; 129(4):661-70. PubMed ID: 10683190
[TBL] [Abstract][Full Text] [Related]
3. Selective cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better alternative for renal colic?
Nakada SY; Jerde TJ; Bjorling DE; Saban R
J Urol; 2000 Feb; 163(2):607-12. PubMed ID: 10647695
[TBL] [Abstract][Full Text] [Related]
4. NS-398 (a selective cyclooxygenase-2 inhibitor) decreases agonist-induced contraction of the human ureter via calcium channel inhibition.
Lee SY; Lee MY; Park SH; Kim TH; Moon YT; Han JH; Myung SC
J Endourol; 2010 Nov; 24(11):1863-8. PubMed ID: 20958135
[TBL] [Abstract][Full Text] [Related]
5. Effects of a non-selective COX inhibitor and selective COX-2 inhibitors on contractility of human and porcine ureters in vitro and in vivo.
Chaignat V; Danuser H; Stoffel MH; Z'brun S; Studer UE; Mevissen M
Br J Pharmacol; 2008 Jul; 154(6):1297-307. PubMed ID: 18500363
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat.
Euchenhofer C; Maihófner C; Brune K; Tegeder I; Geisslinger G
Neurosci Lett; 1998 May; 248(1):25-8. PubMed ID: 9665655
[TBL] [Abstract][Full Text] [Related]
7. NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: role of endothelium.
Adeagbo AS; Patel D; Iddrissu A; Walker J; Thirumalai S; Joshua IG; Schuschke D; Wang Y
Eur J Pharmacol; 2003 Jan; 458(1-2):145-54. PubMed ID: 12498919
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cyclooxygenase 2 (COX-2) in intrinsic tone of isolated guinea pig trachea.
Charette L; Misquitta C; Guay J; Reindeau D; Jones TR
Can J Physiol Pharmacol; 1995 Nov; 73(11):1561-7. PubMed ID: 8789408
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of COX in ocular tissues: an in vitro model to identify selective COX-2 inhibitors.
García-Cabanes C; Palmero M; Bellot JL; Castillo M; Orts A
J Ocul Pharmacol Ther; 2001 Feb; 17(1):67-74. PubMed ID: 11322639
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
Moalic S; Liagre B; Le Bail JC; Beneytout JL
Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
[TBL] [Abstract][Full Text] [Related]
11. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
12. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY
Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519
[TBL] [Abstract][Full Text] [Related]
15. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
Klein T; Neuhaus K; Reutter F; Nüsing RM
Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal antiinflammatory drugs and a selective cyclooxygenase 2 inhibitor uncouple mitochondria in intact cells.
Krause MM; Brand MD; Krauss S; Meisel C; Vergin H; Burmester GR; Buttgereit F
Arthritis Rheum; 2003 May; 48(5):1438-44. PubMed ID: 12746918
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
Elder DJ; Halton DE; Crew TE; Paraskeva C
Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP-kinase-dependent process.
Dunlop ME; Muggli EE
Kidney Int; 2002 May; 61(5):1729-38. PubMed ID: 11967022
[TBL] [Abstract][Full Text] [Related]
20. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.
Futaki N; Yoshikawa K; Hamasaka Y; Arai I; Higuchi S; Iizuka H; Otomo S
Gen Pharmacol; 1993 Jan; 24(1):105-10. PubMed ID: 8482483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
